| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.00058 | 1 |